Loading...

COLL COLLEGIUM PHARMACEUTICAL INC Capital Structure Changes 8-K Filing

CLLG

CLL

COLLEGIUM PHARMACEUTICAL INC

(COLL)

2025 8-K

Company Acquisition

Earnings Report

2026 Revenue Guidance

Credit Agreement Details

Earnings Report

Financial Statements

Management Change

Board Expansion

2025 Financial Guidance

Merger Announcement

CEO Appointment

Merger Completion

Earnings Reports

Merger Agreement and Loan A...

FDA Exclusivity Granted

Appointment, Separation Agr...

Annual Meeting Voting Results

Share Repurchase Agreement

Management Change

Earnings Reports

Authorized Generic Agreement

Redemption of Convertible S...

Earnings Reports

Press Release and Investor ...

Share Repurchase Agreement

FDA Exclusivity Grant

Share Repurchase Agreement

Earnings Reports

Earnings Reports

Financial Results Announcement

Material Definitive Agreement

Earnings Reports

Press Release and Share Rep...

External Links:

Collegium Pharmaceutical, Inc. entered into a new credit agreement on December 23, 2025, allowing for a $580 million term loan and a $300 million delayed draw. The initial loan repaid an existing debt and will bear interest based on SOFR plus 2.75% to 3.75%.

AI Assistant

COLLEGIUM PHARMACEUTICAL INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.